204 related articles for article (PubMed ID: 15857538)
41. [The use of recombinant activated factor VII in the treatment of gastrointestinal bleeding following acetylsalicylic acid therapy in a surgical patient].
Vucelić D; Sabljak P; Pesko P; Stojakov D; Keramatollah E; Nenadić B; Pejović D; Velicković D; Bjelović M
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():240-5. PubMed ID: 19562876
[TBL] [Abstract][Full Text] [Related]
42. Recombinant factor VIIa for treatment of gastrointestinal hemorrhage following rattlesnake envenomation.
Ruha AM; Curry SC
Wilderness Environ Med; 2009; 20(2):156-60. PubMed ID: 19594209
[TBL] [Abstract][Full Text] [Related]
43. Use of recombinant activated factor VIIa for nonsurgical, refractory bleeding in neonatal cardiac surgery patients: case series.
Camkiran A; Pirat A; Zeyneloglu P; Ozkan M; Arslan G
J Cardiothorac Vasc Anesth; 2013 Apr; 27(2):e14-5. PubMed ID: 23507020
[No Abstract] [Full Text] [Related]
44. Recombinant activated factor VII for severe gastrointestinal bleeding after chemotherapy in an infant with acute megakaryoblastic leukemia.
Kurekci AE; Atay AA; Okutan V; Yavuz ST; Ozcan O
Blood Coagul Fibrinolysis; 2005 Mar; 16(2):145-7. PubMed ID: 15741803
[TBL] [Abstract][Full Text] [Related]
45. Successful treatment of massive gastrointestinal hemorrhage in acute biphenotypic leukemia with recombinant factor VIIa (NovoSeven).
Zülfikar B; Kayiran SM
Blood Coagul Fibrinolysis; 2004 Apr; 15(3):261-3. PubMed ID: 15060424
[TBL] [Abstract][Full Text] [Related]
46. [Successful management of massive gastrointestinal bleeding using recombinant factor VIIa in an elderly patient with respiratory and renal failure].
Liu M; Wang G; Ma Q; Ren J; Guo L; Zhang J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jul; 34(8):1215-6. PubMed ID: 25176101
[TBL] [Abstract][Full Text] [Related]
47. Recombinant factor VIIa in the treatment of bleeding.
Midathada MV; Mehta P; Waner M; Fink LM
Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
[TBL] [Abstract][Full Text] [Related]
48. Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair.
Stratmann G; Russell IA; Merrick SH
Ann Thorac Surg; 2003 Dec; 76(6):2094-7. PubMed ID: 14667657
[TBL] [Abstract][Full Text] [Related]
49. Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use.
Sobieszczyk S; Breborowicz GH; Platicanov V; Tanchev S; Kessler CM
Acta Obstet Gynecol Scand; 2006; 85(10):1239-47. PubMed ID: 17068684
[TBL] [Abstract][Full Text] [Related]
50. [Use of recombinant factor VIIa for the control of massive bleeding caused by uterine hypotonia in post-placental period].
Tanchev S; Platikanov V; Markova S; Slavov N; Bogdanova A; Dimitrova D
Akush Ginekol (Sofiia); 2004; 43(1):16-20. PubMed ID: 15168648
[TBL] [Abstract][Full Text] [Related]
51. Recombinant factor VIIa for refractory bleeding following orthotopic heart transplantation.
Flynn JD; Pajoumand M; Camp PC; Jahania MS; Ramaiah C; Akers WS
Ann Pharmacother; 2004 Oct; 38(10):1639-42. PubMed ID: 15340124
[TBL] [Abstract][Full Text] [Related]
52. [The use of recombinant activated factor VII in a patient with uncontrolled bleeding from the gastrointestinal tract].
Vitković R; Petrović I
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():246-8. PubMed ID: 19562877
[TBL] [Abstract][Full Text] [Related]
53. [Activated recombinant factor VII for bleeding after a kidney transplant].
Vidal MA; Sebastianes C; Eizaga R; Martínez E; Torres LM
Rev Esp Anestesiol Reanim; 2005 Dec; 52(10):638-9. PubMed ID: 16435622
[No Abstract] [Full Text] [Related]
54. Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery.
Singh SP; Chauhan S; Choudhary M; Vasdev S; Talwar S
Asian Cardiovasc Thorac Ann; 2012 Feb; 20(1):19-23. PubMed ID: 22371937
[TBL] [Abstract][Full Text] [Related]
55. Recombinant activated factor VII in refractory gastrointestinal haemorrhage of unknown aetiology.
Matic I; Titlic M; Lucic I; Mirkovic F; Jurjevic M
Bratisl Lek Listy; 2008; 109(10):438-40. PubMed ID: 19166127
[TBL] [Abstract][Full Text] [Related]
56. Successful use of activated recombinant factor VII in life threatening bleeding after thoracic surgery.
Kogler VM; Slobodnjak Z; Samarzija M; Macan JS; Karadza V; Jakopovic M
Swiss Med Wkly; 2007 Jul; 137(27-28):407-10. PubMed ID: 17705102
[TBL] [Abstract][Full Text] [Related]
57. Safety and efficiency of recombinant activated factor VII in postcardiotomy massive hemorrhage.
Lamarche Y; Demers P; Poirier NC; Robitaille D; Cartier R
Can J Cardiol; 2007 Aug; 23(10):809-13. PubMed ID: 17703260
[TBL] [Abstract][Full Text] [Related]
58. Use of recombinant factor VII in cardiac surgery.
Elizalde M; Slobodskoy L; Diodato M; Chang J; Chedrawy EG
Recent Pat Cardiovasc Drug Discov; 2012 Dec; 7(3):216-20. PubMed ID: 22812609
[TBL] [Abstract][Full Text] [Related]
59. Open-heart surgery in an infant with heterozygous factor VII deficiency.
Matsuhisa H; Yoshimura N; Niimi H; Ichida F
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1037-8. PubMed ID: 20197348
[TBL] [Abstract][Full Text] [Related]
60. Massive transfusion coagulopathy.
Levy JH
Semin Hematol; 2006 Jan; 43(1 Suppl 1):S59-63. PubMed ID: 16427387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
